2007
DOI: 10.1016/j.drudis.2006.12.003
|View full text |Cite
|
Sign up to set email alerts
|

Scaffold selection and scaffold hopping in lead generation: a medicinal chemistry perspective

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
97
0
1

Year Published

2008
2008
2022
2022

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 138 publications
(98 citation statements)
references
References 36 publications
0
97
0
1
Order By: Relevance
“…org). Multiple, unrelated scaffolds are generally considered necessary because of attrition in hit-to-lead chemistry as a result of issues with chemical tractability for lead optimization, pharmacokinetic liabilities, specificity for the desired target, cost, and other factors (Zhao, 2007). Second, drug discovery will be assisted by our single-channel studies, which provide mechanistic insights into how derivatives may achieve greater potency.…”
Section: Discussionmentioning
confidence: 99%
“…org). Multiple, unrelated scaffolds are generally considered necessary because of attrition in hit-to-lead chemistry as a result of issues with chemical tractability for lead optimization, pharmacokinetic liabilities, specificity for the desired target, cost, and other factors (Zhao, 2007). Second, drug discovery will be assisted by our single-channel studies, which provide mechanistic insights into how derivatives may achieve greater potency.…”
Section: Discussionmentioning
confidence: 99%
“…The ability to identify such novel ring-systems, an ability that is often referred to as scaffold hopping or lead hopping, is a key capability of an effective method for virtual screening [6][7][8][9]. Bohm et al state that "The aim of scaffold hopping is to discover structurally novel compounds starting from known active compounds by modifying the central core structure of the molecule" [10]; and in like vein, Zhou defines scaffold hopping as "a computational technique that identifies a topologically different scaffold from the parent compound but with similar or improved activity and other properties from a given database" [11]. Scaffold hopping is important for three principal reasons: it can provide a back-up if the existing lead series in a project subsequently proves to exhibit poor ADMET properties; some positions around a given scaffold may be synthetically difficult, where as an alternative may enable the creation of the desired substitution pattern; most importantly, it provides a way of circumventing the structural coverage of an existing, competitor patent.…”
Section: Introductionmentioning
confidence: 99%
“…The identification of promising hits and the generation of high quality leads are crucial steps in the early stages of drug discovery [1][2][3]. Advances in medicinal chemistry at the interface of chemistry and biology have created an important foundation in the search for new drug candidates possessing a combination of optimized pharmacodynamic and pharmacokinetic properties.…”
Section: Introductionmentioning
confidence: 99%